Decreased elastase activity in circulating granulocytes of systemic sclerosis patients: A possible pathogenetic role [4]

Scandinavian Journal of Rheumatology

Volumn 34, Issue 6, 2005, Pages 494-495

  Bazzichi, L ^a,c   Rossi, A ^b   Giannaccini, G ^b   Betti, L ^b   Cercignani, G ^b   Giuliano, T ^a   Mascia, G ^b   Lucacchini, A ^b   Bombardieri, S ^a  

^a Division of Rheumatology   (Italy)

^b Department of Psychiatry Neurobiology Pharmacology and Biotechnology ^*

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELASTASE; LEUKOCYTE ELASTASE;

ADULT; BLOOD ANALYSIS; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GEL CHROMATOGRAPHY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LETTER; MALE; MICHAELIS CONSTANT; MONOCYTE; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SYSTEMIC SCLEROSIS; WESTERN BLOTTING;

BLOTTING, WESTERN; FEMALE; GRANULOCYTES; HUMANS; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 30344433430     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740510026670     Document Type: Letter

References (9)

1. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am 1996;22:647-74.
2. Zhu Y, Liu X, Skold CM, Wang H, Kohyama T, Wen FQ, et al. Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels. Respir Res 2001;2:300-5.
3. Janoff A. Elastase in tissue injury. Annu Rev Med 1985;36:207-16.
4. Le Roy EC, Black C, Fleischmajer R. Scleroderma: classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
5. Valentini G, Silman AJ, Veale D. Assessment of disease activity. Clin Exp Rheumatol 2003;21, (3 Suppl 29), S39-41.
6. Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003;21, (3 Suppl 29), S42-6.
7. Nakajima K, Powers JC, Ashe BM, Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J Biol Chem 1979;254:4027-32.
8. Ploug M, Gardsvoll H, Jorgensen TJ, Lonborg Hansen L, Dano K. Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy. Biochem Soc Trans 2002;30:177-83.
9. Lijnen HR. Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems. Fibrinol Proteol 2000;14:175.